Alger Associates, Inc. 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:00 pm Purchase | 2025-09-30 | 13G | Forte Biosciences, Inc. FBRX | Alger Associates, Inc. | 1,634,267 13.100% | 15,618 (+0.96%) | Filing |
| 2025-08-14 4:27 pm Purchase | 2025-06-30 | 13G | Forte Biosciences, Inc. FBRX | Alger Associates, Inc. | 1,618,649 13.300% | 708,040 (+77.75%) | Filing |
| 2025-05-15 7:43 pm Sale | 2025-03-31 | 13G | Forte Biosciences, Inc. FBRX | Alger Associates, Inc. | 910,609 14.200% | -223,335 (-19.70%) | Filing |
| 2025-02-14 5:18 pm Purchase | 2024-12-31 | 13G | Forte Biosciences, Inc. FBRX | Alger Associates, Inc. | 1,133,944 17.700% | 175,019 (+18.25%) | Filing |
| 2024-12-06 4:05 pm Purchase | 2024-11-30 | 13G | Forte Biosciences, Inc. FBRX | Alger Associates, Inc. | 958,925 15.000% | 876,227 (+1059.55%) | Filing |
| 2024-11-14 4:02 pm Purchase | 2024-09-30 | 13G | Forte Biosciences, Inc. FBRX | Alger Associates, Inc. | 82,698 5.700% | 82,698 (New Position) | Filing |